Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C17H31NO |
| Molecular Weight | 265.4341 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCN(CC)CCOCCC1=CC[C@H]2C[C@@H]1C2(C)C
InChI
InChIKey=BZRYYBWNOUALTQ-HOTGVXAUSA-N
InChI=1S/C17H31NO/c1-5-18(6-2)10-12-19-11-9-14-7-8-15-13-16(14)17(15,3)4/h7,15-16H,5-6,8-13H2,1-4H3/t15-,16-/m0/s1
Myrtecaine is an ester series local anasthetic. It has been used by topical application for local pain relief. Myrtecaine is often used in the management of muscle or ligament pain, various rheumatismal disorders. It might be used in its lauryl sulfate form in combination with other active ingredients in the management of gastric pain and burning. Myrtecaine was already being sold OTC, but due to a coding error when revising German drug law, myrtecaine had become an Rx substance from a legal point of view.
Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C245
Created by
admin on Mon Mar 31 18:20:19 GMT 2025 , Edited by admin on Mon Mar 31 18:20:19 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
76969111
Created by
admin on Mon Mar 31 18:20:19 GMT 2025 , Edited by admin on Mon Mar 31 18:20:19 GMT 2025
|
PRIMARY | |||
|
1892
Created by
admin on Mon Mar 31 18:20:19 GMT 2025 , Edited by admin on Mon Mar 31 18:20:19 GMT 2025
|
PRIMARY | |||
|
59082
Created by
admin on Mon Mar 31 18:20:19 GMT 2025 , Edited by admin on Mon Mar 31 18:20:19 GMT 2025
|
PRIMARY | RxNorm | ||
|
231-735-7
Created by
admin on Mon Mar 31 18:20:19 GMT 2025 , Edited by admin on Mon Mar 31 18:20:19 GMT 2025
|
PRIMARY | |||
|
100000084424
Created by
admin on Mon Mar 31 18:20:19 GMT 2025 , Edited by admin on Mon Mar 31 18:20:19 GMT 2025
|
PRIMARY | |||
|
Myrtecaine
Created by
admin on Mon Mar 31 18:20:19 GMT 2025 , Edited by admin on Mon Mar 31 18:20:19 GMT 2025
|
PRIMARY | |||
|
CHEMBL1630579
Created by
admin on Mon Mar 31 18:20:19 GMT 2025 , Edited by admin on Mon Mar 31 18:20:19 GMT 2025
|
PRIMARY | |||
|
9902116282
Created by
admin on Mon Mar 31 18:20:19 GMT 2025 , Edited by admin on Mon Mar 31 18:20:19 GMT 2025
|
PRIMARY | |||
|
C011940
Created by
admin on Mon Mar 31 18:20:19 GMT 2025 , Edited by admin on Mon Mar 31 18:20:19 GMT 2025
|
PRIMARY | |||
|
7712-50-7
Created by
admin on Mon Mar 31 18:20:19 GMT 2025 , Edited by admin on Mon Mar 31 18:20:19 GMT 2025
|
PRIMARY | |||
|
m358
Created by
admin on Mon Mar 31 18:20:19 GMT 2025 , Edited by admin on Mon Mar 31 18:20:19 GMT 2025
|
PRIMARY | Merck Index | ||
|
3787
Created by
admin on Mon Mar 31 18:20:19 GMT 2025 , Edited by admin on Mon Mar 31 18:20:19 GMT 2025
|
PRIMARY | |||
|
C90653
Created by
admin on Mon Mar 31 18:20:19 GMT 2025 , Edited by admin on Mon Mar 31 18:20:19 GMT 2025
|
PRIMARY | |||
|
DTXSID901016796
Created by
admin on Mon Mar 31 18:20:19 GMT 2025 , Edited by admin on Mon Mar 31 18:20:19 GMT 2025
|
PRIMARY | |||
|
SUB09102MIG
Created by
admin on Mon Mar 31 18:20:19 GMT 2025 , Edited by admin on Mon Mar 31 18:20:19 GMT 2025
|
PRIMARY |
ACTIVE MOIETY